Back to News
Market Impact: 0.1
New Supplement Launches to Support Immune Health and Fertility Journey with Anti-Inflammatory and Antioxidant Benefits
Source: PRWeb
Product LaunchesHealthcare & Biotech
Ovaterra introduced Ovamune™, an anti-inflammatory and antioxidant supplement marketed to women over 35. The company says it is intended to complement—not replace—a prenatal vitamin.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.10
More News
- Daiichi Sankyo’s first-half profit rises on cancer drug growth; shares up
- Starbucks serves up a solid quarter and full-year outlook. Why we're staying invested
- We're raising our price target on Eli Lilly as the obesity-drug boom rolls on
- Coinbase net income surges 66% in third quarter, benefiting from bitcoin investment gains
- ATEC Q3 2026 slides show profitability surge despite execution gaps
- West Pharma earnings show it's more than a GLP-1 play. Why we see more upside